DocGo Inc
NASDAQ:DCGO
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.84
6.17
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
DocGo Inc
Cost of Revenue
DocGo Inc
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
DocGo Inc
NASDAQ:DCGO
|
Cost of Revenue
-$428.9m
|
CAGR 3-Years
-90%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Cost of Revenue
-$8.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cost of Revenue
-$6.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-4%
|
|
|
CVS Health Corp
NYSE:CVS
|
Cost of Revenue
-$316.5B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-11%
|
|
|
Cigna Corp
NYSE:CI
|
Cost of Revenue
-$206.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cost of Revenue
-$9.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-9%
|
|
DocGo Inc
Glance View
DocGo, Inc. operates as an emerging growth company, which provides mobile health services. The company is headquartered in New York City, New York. The company went IPO on 2020-10-15. The firm uses dispatch and communication technology to provide healthcare transportation and mobile services in-person medical treatment directly to patients in their homes, workplaces and other non-traditional locations, in various metropolitan cities in the United States and the United Kingdom. The company operates through two segments: medical mobility solutions and mobile health solutions. The Company’s medical mobility solutions are offered under the Ambulnz brand. The company enables access to local clinical services, including primary and specialty care, dialysis treatments for chronic care management, and transfers between clinical settings. The Company’s mobile health solutions include services performed at home and offices, coronavirus disease (COVID-19) testing, and event services, which include on-site healthcare support at sporting events and concerts.
See Also
What is DocGo Inc's Cost of Revenue?
Cost of Revenue
-428.9m
USD
Based on the financial report for Dec 31, 2023, DocGo Inc's Cost of Revenue amounts to -428.9m USD.
What is DocGo Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-90%
Over the last year, the Cost of Revenue growth was -50%. The average annual Cost of Revenue growth rates for DocGo Inc have been -90% over the past three years .
You don't have any saved screeners yet
